SERIES A CONVERTIBLE PREFERRED SUBSCRIPTION AGREEMENT AMONG NOVAVAX, INC. AND THE INVESTOR NAMED HEREIN Dated as of JUNE 15, 2020Series a Convertible Preferred Subscription Agreement • June 19th, 2020 • Novavax Inc • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledJune 19th, 2020 Company Industry JurisdictionThis SERIES A CONVERTIBLE PREFERRED SUBSCRIPTION AGREEMENT (this “Agreement”) is made and entered into this 15th day of June, 2020 by and among Novavax, Inc., a Delaware corporation (the “Company”), and the Person named on the signature page hereto under the heading “Investor” (the “Investor”). Certain terms used and not otherwise defined in the text of this Agreement are defined in Section 7 hereof.